CRCM
IDXX icon

Crystal Rock Capital Management’s Idexx Laboratories IDXX Stock Holding History

Crystal Rock Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.58M Buy
10,600
+1,075
+11% +$603K 2.84% 14
2026
Q1 		$5.35M Sell
9,525
-355
-4% -$228K 3.18% 10
2025
Q4 		$6.68M Hold
9,880
– – 3.53% 12
2025
Q3 		$6.31M Sell
9,880
-705
-7% -$428K 3.45% 11
2025
Q2 		$5.68M Sell
10,585
-600
-5% -$287K 3.27% 12
2025
Q1 		$4.7M Buy
11,185
+2,180
+24% +$947K 3.21% 12
2024
Q4 		$3.72M Hold
9,005
– – 2.28% 17
2024
Q3 		$4.55M Buy
9,005
+4,265
+90% +$2.07M 2.68% 14
2024
Q2 		$2.31M Buy
+4,740
New +$2.38M 1.38% 23
2022
Q2 		– Sell
-4,175
Closed -$2.28M – 29
2022
Q1 		$2.28M Sell
4,175
-2,215
-35% -$1.17M 1.51% 26
2021
Q4 		$4.21M Sell
6,390
-275
-4% -$173K 2.27% 19
2021
Q3 		$4.14M Sell
6,665
-785
-11% -$527K 2.2% 21
2021
Q2 		$4.71M Hold
7,450
– – 2.45% 16
2021
Q1 		$3.65M Hold
7,450
– – 1.98% 22
2020
Q4 		$3.72M Hold
7,450
– – 2.13% 21
2020
Q3 		$2.93M Buy
7,450
+500
+7% +$185K 1.85% 23
2020
Q2 		$2.29M Hold
6,950
– – 1.59% 25
2020
Q1 		$1.68M Hold
6,950
– – 1.49% 23
2019
Q4 		$1.81M Hold
6,950
– – 1.18% 28
2019
Q3 		$1.89M Buy
6,950
+1,525
+28% +$424K 1.39% 25
2019
Q2 		$1.49M Buy
+5,425
New +$1.34M 1.1% 26

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Crystal Rock Capital Management's IDXX Position: Q2 2026 in Review

Crystal Rock Capital Management increased its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, buying an estimated $603K and bringing the position to 10,600 shares worth $5.58M. The position accounts for 2.84% of the portfolio, ranked #14.

Crystal Rock Capital Management first reported a position in IDXX in Q2 2019 and has held it in 21 quarters since. The position peaked at $6.68M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Crystal Rock Capital Management held 10,600 shares of Idexx Laboratories worth $5.58M as of Q2 2026.
  • Crystal Rock Capital Management bought 1,075 Idexx Laboratories shares in Q2 2026, an estimated $603K.
  • Idexx Laboratories made up 2.84% of Crystal Rock Capital Management's portfolio in Q2 2026, its #14 holding.
  • Crystal Rock Capital Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 21 quarters since.
  • Crystal Rock Capital Management's Idexx Laboratories position peaked at $6.68M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Crystal Rock Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.